Facebook
Twitter
LinkedIn
ForwardPediatrics Research Week 2021
Research Week is an event that spotlights the scholarly work from the departments residents, fellows, faculty, reserachers and staff. Through a mix of livestreamed lectures and interactive sessions, Research Week’s celebration of scholarship will be virtually available to the University of Wisconsin School of Medicine and Public Health community and anyone interested in the latest advances in pediatric research. Activities for the week include small group sessions with faculty and trainees to discuss QI projects, mentoring and cross departmental research, the distinguished Gerard B. Odell Lecture, a Faculty Research Forum, platform presentations, and an online poster session featuring the research of residents, fellows, faculty and staff.
Intended Audience
This activity is intended for physicians, nurses, advanced practice providers (PA/NP), researchers, staff, fellows, residents, and students conducting and/or participating in research within the Department of Pediatrics.
Learning Objectives
- Describe key attributes of a successful Quality Improvement project
- Identify best practices for developing research projects to facilitate career advancement
- Discuss mechanisms for promoting collaborative research in Pediatrics
- Explain at least 3 QI initiatives presented during the activity, including at least one that addresses health care disparities
- Summarize best practices for how to write a grant for research
Monday, May 24 | |
| 8:00 AM - 9:00 AM | Morning Report, Quality Improvement |
Kristin Shadman, MD: From Project to Promotion: Breaking down the barriers to QI scholarly work Christine Brichta, MD, MPH: Improving pediatric obesity comorbidity screening in primary care clinics | |
Tuesday, May 25 | |
| 8:00 AM - 9:00 AM | Morning Report, Grant Funding |
Jesse Boyette Anderson, MD: Granted: Getting your project funded & staffed Christine Brichta, MD, MPH and Paige Condit, MD: Grant writing for the first time: Where to start | |
Wednesday, May 16 | |
| 8:00 AM - 9:00 AM | Morning Report, COVID TOES |
| Anne Marie Singh, MD and Lisa Arkin, MD | |
| Faculty Research Forum | |
| 9:15 AM - 9:30 AM | Mei Baker, MD – Statewide Newborn Screening for Spinal Muscular Atrophy: the Wisconsin Experience |
| 9:30 AM - 9:45 AM | Jessica Babal, MD – Using group concept mapping approach to understand how pediatric residents and residency leadership conceptualize resident well-being |
| 9:45 AM - 10:00 AM | Emma Mohr, MD, PhD – Improving developmental outcomes in congenital infections |
| 10:00 AM - 10:15 AM | Christian Capitini, MD – Adoptive cell therapy for GD2+ cancers |
| 10:15 AM - 10:30 AM | Yury Bochkov, PhD – Development of experimental rhinovirus C vaccine |
| Break | |
| 10:45 AM - 11:00 AM | J. Carter Ralphe, MD – Title Forthcoming |
| 11:00 AM - 11:15 AM | Paul Sondel, MD, PhD – New approaches towards inducing potent in vivo immune-mediated destruction of neuroblastoma in preclinical model |
| 11:15 AM - 11:30 AM | Emily Ruedinger, MD, MED – Activism through education: Development and evaluation of a longitudinal curriculum on social justice (this a work in progress) |
| 11:30 AM - 11:45 AM | Huichuan Lai, PhD, RD – Gut microbiome in young children with cystic fibrosis (CF): Comparison with their non-CF siblings and influence of probiotics |
| 11:45 AM - 12:00 PM | Bikash Pattnaik, PhD – Title Forthcoming |
| 12:00 PM - 12:15 PM | Matthew Harer, MD – Neonatal Acute Kidney Injury is Poorly Documented as a Discharge Diagnosis: Findings from the AWAKEN Cohort |
| 12:15 PM - 1:00 PM | Town Hall |
| Trish Barribeau and Chrissy Pientok | |
Thursday, May 27 | |
| 7:30 AM - 8:30 AM | Pediatric Grand Rounds* |
Neuroimaging in Pediatric Brain Injury: A Bridge from Bench to Bedside Peter Ferrazzano, MD – The Enid and Jerry Weygandt Professor of Pediatric Critical Care | |
*Credit for this session offered separately from this activity
Friday, May 28 | |
| 1:00 PM - 1:30 PM | Odell Award Winner Presentation |
| Bikash Pattnaik, PhD – Serendipity in life and science is being the first to see it in a new way | |
| Platform Presentations | |
| 1:30 PM - 1:45 PM | Paige Condit, MD – Establishing normal renal tissue oxygenation values in preterm neonates |
| 1:45 PM - 2:00 PM | Brady Hauser, MD – Accurate Assessment of Adverse Outcomes of Neonatal Circumcision |
| 2:00 PM - 2:15 PM | Brittney Moore – Comparison of structural brain imaging in infant macaques with prenatal Zika virus exposure in early and mid-first trimester |
| 2:15 PM - 2:30 PM | Henry Zapata Galarza, MD – Translational Read-through of a KCNJ13 nonsense mutation with ELX-01 and ELX-03 results in functional Kir7.1 channels. |
| 2:30 PM - 2:45 PM | Santhi Logel, MD – Transgender and Gender-Diverse Youth Have Higher Prevalence of Autoimmune Disease |
| 2:45 PM - 3:00 PM | Doug Dean, PhD – Rapid and Motion-Corrected Multiparametric Imaging in Young Children |
| 3:00 PM - 3:30 PM | Break & Viewing time for virtual posters and abstracts^ |
| 3:30 PM - 5:00 PM | Virtual Poster Session^ |
^Indicates session is not eligible for credit
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be commercial interests.
Relevant Disclosures
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Lisa Arkin | Speaker/Author | AbbVie (Contractor), Regeneron Pharmaceuticals, Inc. (Contractor) | No |
JESSICA BABAL | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
MEI BAKER | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Trish BARRIBEAU | Committee Member | No relevant relationships with ineligible companies to disclose | No |
YURY BOCHKOV | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Jesse Boyett Anderson | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
CHRISTINE BRICHTA | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Christian Capitini | Speaker/Author | Nektar Therapeutics (Contractor), Novartis (Contractor) | No |
SHANE COLVIN | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
PAIGE CONDIT | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Doug Dean III | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
JOHN FROHNA | Course Director | No relevant relationships with ineligible companies to disclose | No |
JAMES GERN | Course Director | Gossamer Bio (Contractor), MeissaVaccines Inc. (Contractor), AstraZeneca (Contractor) | No |
MATTHEW HARER | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
BRADY HAUSER | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Huichuan Lai | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
SANTHI LOGEL | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
EMMA MOHR | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
BRITTNEY MOORE | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
BIKASH PATTNAIK | Speaker/Author | Gene Therapy for LCA16 Blindness (Patent), HubbleTherapeutics (Contractor) | No |
Christine PIENTOK | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
JOHN RALPHE | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
EMILY RUEDINGER | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Kristin Shadman | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
ANNE SINGH | Speaker/Author | AbbVie, Inc. (Contractor) | No |
DAN SKLANSKY | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Paul Sondel | Speaker/Author | Invenra (Contractor) | No |
Kim Stevenson | Committee Member | No relevant relationships with ineligible companies to disclose | No |
HENRY ZAPATA GALARZA | Speaker/Author | No relevant relationships with ineligible companies to disclose | Yes |
 | Accreditation Statement In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
American Medical Association (AMA) Continuing Education Units (CEUs) | |
Available Credit
- 8.75 AMA PRA Category 1 Credit™
- 8.75 University of Wisconsin–Madison Continuing Education Hours
- 8.75 Approved for AMA PRA Category 1 Credit™